NONTOLERANCE TO THE OPIOID ANTAGONISM OF NALTREXONE

被引:37
作者
KLEBER, HD
KOSTEN, TR
GASPARI, J
TOPAZIAN, M
机构
关键词
D O I
10.1016/0006-3223(85)90136-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:66 / 72
页数:7
相关论文
共 12 条
[1]  
Douglas W. W., 1980, PHARMACOL BASIS THER, P609
[2]  
HARRIGAN SE, 1978, J PHARMACOL EXP THER, V204, P481
[3]   THE ADDICTION RESEARCH-CENTER INVENTORY - APPENDIX .1. ITEMS COMPRISING EMPIRICAL SCALES FOR 7 DRUGS .2. ITEMS WHICH DO NOT DIFFERENTIATE PLACEBO FROM ANY DRUG CONDITION [J].
HILL, HE ;
HAERTZEN, CA ;
WOLBACH, AB ;
MINER, EJ .
PSYCHOPHARMACOLOGIA, 1963, 4 (03) :184-205
[4]  
HURZELER M, 1976, National Institute on Drug Abuse Research Monograph, V9, P48
[5]   FAMILY DENIAL AS A PROGNOSTIC FACTOR IN OPIATE ADDICT TREATMENT OUTCOME [J].
KOSTEN, TR ;
JALALI, B ;
HOGAN, I ;
KLEBER, HD .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1983, 171 (10) :611-616
[6]   STRATEGIES TO IMPROVE COMPLIANCE WITH NARCOTIC-ANTAGONISTS [J].
KOSTEN, TR ;
KLEBER, HD .
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 1984, 10 (02) :249-266
[7]  
MARTIN WR, 1973, ARCH GEN PSYCHIAT, V28, P784
[8]  
VEREBEY K, 1976, CLIN PHARMACOL THER, V20, P315
[9]  
VOLAVKA J, 1974, ARCH GEN PSYCHIAT, V30, P677
[10]  
WIKLER A, 1976, National Institute on Drug Abuse Research Monograph, V9, P119